
Lupin Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin